Lycopene content was measured according to Fish et al. [15], following the modifications described in [10].
Line 14 builds equivalence classes on (D_{mathrm{repr}}), with the modifications described in Sect.
The EXIT curves with and without the modifications described in the previous section are illustrated in Figure6.
Further modifications described herein led to compounds that possessed antibacterial activity, which was shown to occur through inhibition of GlmU.
The column setup (Additional file 1: Figure S5) and leaching procedure referred an OECD method [53] with some modifications described in our previous study [32].
Thus, the X-specific transcriptome modifications described here appear genuine.
Screen conditions were in principle similar to methods described earlier [39], with modifications described below.
Experiments were conducted essentially as previously described [20] with modifications described in Methods S1.
Cryo-scanning electron microscopy and x-ray microanalysis was performed as described previously [9] with modifications described in Methods S1.
Specific GS activity was determined by the method of Levintow [93] with minor modifications described by Gebhardt and Williams [94].
Polyacrylamide gels of varying stiffness were prepared as reported previously [54] with the modifications described in [55].
